医学部内視鏡センター

Medicine & Life Sciences

1. Ulcerative Colitis 100%
2. Crohn Disease 47%
3. Capsule Endoscopy 39%
4. Inflammatory Bowel Diseases 31%
5. Endoscopic Mucosal Resection 31%
6. Colitis 26%
7. Colonoscopy 26%
8. Capsule Endoscopes 23%
9. Stomach 22%
10. Colon 21%
11. Mesalamine 20%
12. Infliximab 20%
13. Hemorrhage 19%
14. Endoscopy 17%
15. Mucous Membrane 15%
16. Therapeutics 14%
17. Single-Balloon Enteroscopy 13%
18. Neoplasms 13%
19. Helicobacter pylori 12%
20. Adenoma 11%
21. vedolizumab 11%
22. Capsules 10%
23. Prospective Studies 10%
24. Feasibility Studies 9%
25. Confidence Intervals 9%
26. Steroids 9%
27. Placebos 9%
28. Japan 9%
29. Randomized Controlled Trials 9%
30. Stomach Neoplasms 8%
31. Recurrence 8%
32. Lymphocytes 8%
33. Indigo Carmine 8%
34. Colorectal Neoplasms 8%
35. Organoids 8%
36. Small Intestine 7%
37. Safety 7%
38. Surgical Instruments 7%
39. Ulcer 7%
40. Pancreatitis 7%
41. Inflammation 7%
42. Ileum 7%
43. Sigmoid Colon 6%
44. Blood Component Removal 6%
45. Endoscopic Hemostasis 6%
46. Dextran Sulfate 6%
47. Genes 6%
48. Gastrointestinal Endoscopy 6%
49. Balloon Enteroscopy 6%
50. Water 6%
51. Polyps 6%
52. Gastrointestinal Tract 6%
53. Tacrolimus 6%
54. Gastrointestinal Microbiome 6%
55. Liver 6%
56. T-Lymphocytes 6%
57. sitafloxacin 6%
58. Ribavirin 5%
59. Serum 5%
60. Biopsy 5%
61. Interferons 5%
62. Antibodies 5%
63. Gastroscopy 5%
64. Double-Blind Method 5%
65. Intestinal Diseases 5%
66. Intestinal Mucosa 5%
67. Amoebic Dysentery 5%
68. Odds Ratio 5%
69. Pyogenic Granuloma 5%